Weight loss drugs, Alzheimer's treatments and gene editing: Enormous firsts defined 2023 in pharma

Wall Street turned its focus to a handful of newer treatments in different disease areas in 2023, including weight loss medications and a new Alzheimer's drug.

from Health and Science https://ift.tt/QapxhjB
https://ift.tt/zRncLXi
https://ift.tt/7q1t59c